Munc-18-1 inhibits phospholipase D activity by direct interaction in an epidermal growth factor-reversible manner
Hye Young Lee1, Jong Bae Park, Il Ho Jang
1Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, 790-784 Republic of Korea.
Abstract:
Mammalian phospholipase D (PLD) has been reported to be a key enzyme for epidermal growth factor (EGF)-induced cellular signaling, however, the regulatory mechanism of PLD is still unclear. In this report, we found that Munc-18-1 is a potent negative regulator of PLD in the basal state and that its inhibition is abolished by EGF stimulation. We investigated PLD-binding proteins obtained from rat brain extract, and identified a 67-kDa protein as Munc-18-1 by peptide-mass finger-printing. The direct association between PLD and Munc-18-1 was confirmed by in vitro binding analysis using the purified proteins, and their binding sites were identified as the phox homology domain of PLD and multiple sites of Munc-18-1. PLD activity was potently inhibited by Munc-18-1 in vitro (IC50 = 2-5 nm), and the cotransfection of COS-7 cells with Munc-18-1 and PLD inhibited basal PLD activity in vivo. In the basal state, Munc-18-1 coprecipitated with PLD and colocalized with PLD2 at the plasma membrane of COS-7 cells. EGF treatment triggered the dissociation of Munc-18-1 from PLD when PLD was activated by EGF. The dissociation of the endogenous interaction between Munc-18-1 and PLD, and the activation of PLD by EGF were also observed in primary cultured chromaffin cells. These results suggest that Munc-18-1 is a potent negative regulator of basal PLD activity and that EGF stimulation abolishes this interaction.
Insights
Munc-18-1 negatively regulates phospholipase D (PLD) activity. Epidermal growth factor (EGF) stimulation disrupts this interaction, activating PLD signaling pathways.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Signaling
Background:
- Mammalian phospholipase D (PLD) is crucial for epidermal growth factor (EGF)-induced cellular signaling.
- The precise regulatory mechanisms governing PLD activity remain incompletely understood.
Purpose of the Study:
- To identify regulatory proteins of PLD.
- To elucidate the role of Munc-18-1 in PLD regulation.
- To investigate the effect of EGF stimulation on the PLD-Munc-18-1 interaction.
Main Methods:
- Protein identification via peptide-mass fingerprinting.
- In vitro binding assays with purified proteins.
- Co-transfection and activity assays in COS-7 cells.
- Immunoprecipitation and co-localization studies.
- Analysis in primary cultured chromaffin cells.
Main Results:
- Munc-18-1 was identified as a PLD-binding protein.
- Munc-18-1 potently inhibits basal PLD activity in vitro and in vivo.
- Munc-18-1 interacts with and colocalizes with PLD2 at the plasma membrane.
- EGF stimulation causes Munc-18-1 dissociation from PLD, leading to PLD activation.
Conclusions:
- Munc-18-1 acts as a significant negative regulator of basal PLD activity.
- EGF signaling abolishes the inhibitory interaction between Munc-18-1 and PLD, enabling PLD activation.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Abnormal Proliferation
Amplifying Signals via Enzymatic Cascade
IP3/DAG Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...

